• Users Online: 344
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 10  |  Issue : 4  |  Page : 197-201

Detection of acid sphingomyelinase in human saliva and its advantages in the diagnosis of Niemann-Pick disease type B


1 Centro de Estudio de las Metabolopatías Congénitas, School of Medicine, Hospital de Niños de la Santísima Trinidad, Universidad Nacional de Córdoba, Córdoba, Argentina
2 Centro de Estudio de las Metabolopatías Congénitas, School of Medicine, Hospital de Niños de la Santísima Trinidad; Department of Cellular Biology, Chair “B”, School of Dentistry, Universidad Nacional de Córdoba, Córdoba, Argentina

Correspondence Address:
Lidia Dora Martínez
Professor, School of Dentistry, National University of Córdoba, Haya de la Torre S/N, Córdoba
Argentina
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JCSR.JCSR_95_20

Rights and Permissions

Background: Niemann-Pick disease type B is an autosomal recessive lysosomal storage disorder caused by a deficiency of acid sphingomyelinase (ASM) coded by SMPD1 gene. Diagnostic assays for this enzyme were developed using fibroblasts, leukocytes, plasma and dry blood spots, however, there are no expression studies in saliva in the literature, so far. Saliva is a biofluid used to analyze the health/disease condition of an individual. Methods: We standardized a fluorometric method to determine ASM activity in human saliva of control subjects and in one NPD-B patient. Results: ASM activity was detected in all saliva samples. The range of ASM in saliva of 28 control subjects was 4.5 - 70.4 with an average of 26.93 ± 15.7 nmol/17h/mg of protein. Values in plasma were significantly lower, a 0.056- 3.2 range, with an average of 0.85 ± 0.7 nmol/17h/mg of protein. There was no correlation between saliva and plasma samples (R2= 0.001). ASM was markedly deficient in saliva activity of (0.09 nmol/17h/ mg of protein) as well as in the leukocyte pellet (0.125 nmol/17h/mg protein) and in the plasma (0.68 nmol/17h) of the NPD-B patient. Conclusion: Our observations indicate that saliva could be an alternative biofluid to plasma and to leucocytes to measure ASM activity, representing a non-invasive, easy-collection diagnostic means, which would allow the identification and characterization of these entities.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed282    
    Printed0    
    Emailed0    
    PDF Downloaded46    
    Comments [Add]    

Recommend this journal